KDM5B Produits
(Lysine (K)-Specific Demethylase 5B (KDM5B))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories KDM5B en vedette
KDM5B Anticorps
High quality antibodies with extensive validation data.
KDM5B Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
KDM5B recommandé Anticorps
- (3)
- (8)
- (4)
- (3)
KDM5B recommandé Protéines
- (3)
- (1)
Dernières publications sur nos produits KDM5B
: "Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma. ..." dans: European journal of cancer (Oxford, England : 1990), Vol. 109, pp. 137-153, (2019) (PubMed).: "Targeting the H3K4 demethylase KDM5B reprograms the metabolome and phenotype of melanoma cells." dans: The Journal of investigative dermatology, (2019) (PubMed).
: "Blockade of Immune-Checkpoint B7-H4 and Lysine Demethylase 5B in Esophageal Squamous Cell Carcinoma Confers Protective Immunity against P. gingivalis Infection." dans: Cancer immunology research, Vol. 7, Issue 9, pp. 1440-1456, (2019) (PubMed).
: "CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity." dans: Cancer research, Vol. 76, Issue 13, pp. 3965-77, (2016) (PubMed).
: "Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448." dans: BMC cancer, Vol. 16, pp. 160, (2016) (PubMed).
: "PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma." dans: Oncology reports, Vol. 33, Issue 5, pp. 2454-60, (2015) (PubMed).
: "SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination." dans: Oncotarget, Vol. 6, Issue 2, pp. 771-88, (2015) (PubMed).
: "Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer." dans: Tumour biology, Vol. 36, Issue 4, pp. 2465-72, (2015) (PubMed).
: "The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers." dans: Cell reports, Vol. 6, Issue 2, pp. 325-35, (2014) (PubMed).
: "Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry." dans: Pigment cell & melanoma research, Vol. 27, Issue 3, pp. 442-53, (2014) (PubMed).
Synonymes et noms alternatifs relatifs à KDM5B
lysine (K)-specific demethylase 5Ba (kdm5ba), lysine (K)-specific demethylase 5Bb (kdm5bb), lysine demethylase 5B (KDM5B), lysine (K)-specific demethylase 5B (Kdm5b), lysine (K)-specific demethylase 5B (KDM5B), lysine demethylase 5B (Kdm5b), 2010009J12Rik, 2210016I17Rik, AW556288, cb264, CT31, D1Ertd202e, id:ibd5050, jarid1b, JARID1B, Jarid1b, jarid1ba, jarid1bb, mKIAA4034, PLU-1, plu1, PLU1, Plu1, PUT1, Rb-Bp2, RBBP2H1A, RGD1565602, wu:fc44h11, wu:fd15c05, zgc:85741Protein level used designations for KDM5B
- jumonji, AT rich interactive domain 1B (Rbp2 like)
- jumonji, AT rich interactive domain 1Ba (Rbp2 like)
- histone demethylase JARID1B-B
- jumonji/ARID domain-containing protein 1B-B
- lysine-specific demethylase 5B-B
- putative DNA/chromatin binding motif
- lysine (K)-specific demethylase 5B
- Jumonji, AT rich interactive domain 1B (RBP2-like)
- jumonji, AT rich interactive domain 1B
- lysine-specific demethylase 5B-like
- RBP2-H1
- cancer/testis antigen 31
- histone demethylase JARID1B
- jumonji/ARID domain-containing protein 1B
- lysine-specific demethylase 5B
- retinoblastoma-binding protein 2 homolog 1
- retinoblastoma-binding protein 2, homolog 1A
- putative DNA/chromatin binding motif 1